CSIMarket
 
Veru Inc   (VERU)
Other Ticker:  
 
 

Veru Inc's Suppliers Performance

VERU's Supply Chain

 
VERU Costs vs Sales of Suppliers Growth Veru Inc's cost of sales deteriorated by -18.38 % year on year, relative to one quarter ago cost of sales fell by -14.98 % in Q3.

More on VERU Suppliers




Veru Inc's cost of sales deteriorated by -18.38 % year on year, compare to one quarter ago cost of sales fell by -14.98 % in Q3.

More on VERU Suppliers



  News about Veru Inc Contracts

Advancing Muscle Loss Treatment: Veru's FDA Clearance of IND Application for Enobosarm

In a significant breakthrough for Veru, the pharmaceutical company recently announced the clearance of its Investigational New Drug (IND) application by the FDA. This crucial milestone paves the way for the initiation of Phase 2b clinical trials with Enobosarm, which aims to treat muscle loss associated with weight loss drugs. Furthermore, this trial will explore the combination of Enobosarm with GLP-1 drugs for potentially superior weight loss outcomes compared to GLP-1 drug use alone.Facts:The FDA has granted Veru clearance on its IND application, permitting the company to move forward with Phase 2b clinical trials for Enobosarm.Enobosarm is being developed as a potential treatment for muscle loss that com...

Muscle-Preserving Marvel: Veru's Enobosarm Revitalizes Weight Loss Approaches

Veru Inc., a leading biopharmaceutical company dedicated to addressing obesity and other critical medical conditions, recently submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA). This milestone application focuses on the development of enobosarm, a novel medication designed to prevent muscle loss while augmenting fat loss in combination with GLP-1 drugs for weight loss. In this article, we delve into the significance of this development, assessing its potential impact on Veru Inc. and the treatment of obesity.Interpreting Veru's IND Application:Obesity remains a significant global health concern, with its prevalence steadily rising in recent years. Veru's d...




Veru Inc's Comment on Supply Chain









VERU's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Veru Inc 49.08 15.57 -93.09 1,300
SUBTOTAL 0.00 0.00 0.00 -


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com